We are live on ! Find out more
AWMDMG

Austin W. Marxe & David M. Greenhouse Portfolio holdings

AUM $733M
1-Year Est. Return 21.72%
This Fund
S&P 500
This Quarter Est. Return
-2.59%
1 Year Est. Return
+21.72%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$733M
AUM Growth
-$56.2M
Cap. Flow
-$36.1M
Cap. Flow %
-4.93%
Top 10 Hldgs %
30.42%
Holding
157
New
17
Increased
36
Reduced
24
Closed
9

Top Buys

Rank Stock Value
1
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
+$21.6M
2
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
+$6.41M
3
PFNX
Pfenex Inc.
PFNX
+$6.4M
4
CLRB icon
Cellectar Biosciences
CLRB
+$6.39M
5
WGBS
WaferGen Bio-systems, Inc.
WGBS
+$6.24M

Top Sells

Rank Stock Value
1
ARWR icon
Arrowhead Research
ARWR
+$12M
2
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$10.9M
3
SIMO icon
Silicon Motion
SIMO
+$9.87M
4
OVTI
OMNIVISION TECHNOLOGIES INC
OVTI
+$9.86M
5
DEST
Destination Maternity Corporation
DEST
+$6.83M

Sector Composition

Rank Sector Weight
1 Technology 32.64%
2 Industrials 15.3%
3 Healthcare 14.48%
4 Consumer Discretionary 1.14%
5 Financials 0.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LTBR icon
76
Lightbridge
LTBR
$271M
$2.02M 0.28%
14,652
-6,216
-30% -$1.03M
MRIN
77
DELISTED
Marin Software
MRIN
$1.97M 0.27%
5,439
– –
PRKR
78
DELISTED
Parkervision Inc
PRKR
$1.81M 0.25%
159,000
+20,000
+14% +$253K
PARN
79
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$1.79M 0.24%
310,616
– –
ARWR icon
80
Arrowhead Research
ARWR
$11.9B
$1.75M 0.24%
118,733
-877,482
-88% -$12M
MRNS
81
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.73M 0.24%
+66,834
New +$2.06M
SHSP
82
DELISTED
SharpSpring, Inc.
SHSP
$1.71M 0.23%
266,971
-53,029
-17% -$332K
BEAT
83
DELISTED
BioTelemetry, Inc.
BEAT
$1.68M 0.23%
250,182
+45,000
+22% +$316K
AMRC icon
84
Ameresco
AMRC
$1.12B
$1.67M 0.23%
244,062
+212,552
+675% +$1.6M
ACAD icon
85
Acadia Pharmaceuticals
ACAD
$4.43B
$1.64M 0.22%
66,357
– –
RGDX
86
DELISTED
RESPONSE GENETICS, INC COMMON SHS (DELAWARE)
RGDX
$1.59M 0.22%
2,319,879
– –
YUME
87
DELISTED
YuMe, Inc.
YUME
$1.55M 0.21%
310,200
-342,340
-52% -$1.92M
RGLS
88
DELISTED
Regulus Therapeutics
RGLS
$1.54M 0.21%
1,875
– –
MBII
89
DELISTED
Marrone Bio Innovations, Inc.
MBII
$1.51M 0.21%
568,685
+168,685
+42% +$1.13M
IRMD icon
90
iRadimed
IRMD
$1.16B
$1.47M 0.2%
+210,285
New +$1.9M
PIOI
91
DELISTED
Active Power Inc
PIOI
$1.45M 0.2%
725,000
– –
SSNI
92
DELISTED
Silver Spring Networks, Inc.
SSNI
$1.39M 0.19%
+143,739
New +$1.56M
CIMT
93
DELISTED
CIMATRON LTD ORD SHS
CIMT
$1.35M 0.18%
224,467
+1,000
+0.4% +$6.19K
TPST icon
94
Tempest Therapeutics
TPST
$13.7M
$1.32M 0.18%
27
– –
OSN
95
DELISTED
Ossen Innovation Co., Ltd.
OSN
$1.32M 0.18%
373,846
-10,530
-3% -$28.5K
XCRA
96
DELISTED
Xcerra Corporation
XCRA
$1.24M 0.17%
+126,900
New +$1.26M
KIN
97
DELISTED
Kindred Biosciences, Inc.
KIN
$1.21M 0.17%
131,090
– –
SFXE
98
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
$1.2M 0.16%
239,722
– –
VSTM icon
99
Verastem
VSTM
$510M
$1.19M 0.16%
11,667
– –
EGAN icon
100
eGain
EGAN
$187M
$1.18M 0.16%
197,300
+30,000
+18% +$194K
2 3
4
5 6

Similar funds

NAM
Nexus Asset Management New York $725M AUM 12.9% 1-Year Est. Return
KFS
KMS Financial Services Seattle, Washington $713M AUM 14.21% 1-Year Est. Return
WIC
Wood Investment Counsel Denver, Colorado $669M AUM 20.44% 1-Year Est. Return
CHFS
Cobble Hill Financial Services Moorestown, New Jersey $541M AUM 8.99% 1-Year Est. Return
ST
Stifel Trust St. Louis, Missouri $522M AUM 16.39% 1-Year Est. Return
CFS
Community Financial System Dewitt, New York $457M AUM 10.01% 1-Year Est. Return
QLMGAA
QS Legg Mason Global Asset Allocation New York $1.04B AUM 9.55% 1-Year Est. Return
AAM
Archipel Asset Management Stockholm, Sweden $346M AUM 3.54% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's Q3 2014 Portfolio in Review

As of Q3 2014, Austin W. Marxe & David M. Greenhouse held 157 positions worth $733M, down 7.1% from $789M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Austin W. Marxe & David M. Greenhouse withdrew a net $36.1M in Q3 2014, closing 9 positions and reducing 24 holdings. Its most notable exit was Tetraphase Pharmaceuticals, Inc., an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Austin W. Marxe & David M. Greenhouse opened a new position in VITAE PHARMACEUTICALS INC COMMON STOCK worth $6.29M.

  • Austin W. Marxe & David M. Greenhouse's largest Q3 2014 buy was VITAE PHARMACEUTICALS INC COMMON STOCK: 825,000 shares worth $6.29M.
  • Austin W. Marxe & David M. Greenhouse added most to VOCERA COMMUNICATIONS, INC. in Q3 2014, an estimated $21.6M increase.
  • Austin W. Marxe & David M. Greenhouse's biggest Q3 2014 reduction was Arrowhead Research, cutting an estimated $12M.
  • Austin W. Marxe & David M. Greenhouse fully exited Tetraphase Pharmaceuticals, Inc. in Q3 2014, selling an estimated $10.9M.
  • Austin W. Marxe & David M. Greenhouse's ten largest holdings make up 30% of its $733M portfolio in Q3 2014.
  • Austin W. Marxe & David M. Greenhouse opened 17 new positions and closed 9 in Q3 2014.
  • Austin W. Marxe & David M. Greenhouse's portfolio value fell 7.1% quarter-over-quarter to $733M.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.